Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Iradimed (IRMD) just unveiled an announcement.
IRADIMED CORPORATION, a medical device company, has announced its uplisting from the Nasdaq Capital Market to the Nasdaq Global Market, effective June 14, 2024. This move signifies the company’s compliance with higher financial and corporate governance standards required by the Nasdaq Global Market. Shareholders and investors can look forward to continued trading under the ticker “IRMD,” reflecting the company’s growth and potential for increased visibility in the financial markets.
For a thorough assessment of IRMD stock, go to TipRanks’ Stock Analysis page.
